# A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp

> **NCT03285477** · PHASE3 · COMPLETED · sponsor: **Almirall, S.A.** · enrollment: 351 (actual)

## Conditions studied

- Actinic Keratoses

## Interventions

- **DRUG:** Placebo
- **DRUG:** KX2-391 Ointment 1%

## Key facts

- **NCT ID:** NCT03285477
- **Lead sponsor:** Almirall, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-18
- **Primary completion:** 2018-05-03
- **Final completion:** 2019-04-24
- **Target enrollment:** 351 (ACTUAL)
- **Last updated:** 2021-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03285477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03285477, "A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03285477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*